Stephen Andre
Ufficiale delle Risorse Umane presso CULLINAN THERAPEUTICS, INC.
Posizioni attive di Stephen Andre
Società | Posizione | Inizio | Fine |
---|---|---|---|
CULLINAN THERAPEUTICS, INC. | Ufficiale delle Risorse Umane | 01/04/2022 | - |
Storia della carriera di Stephen Andre
Precedenti posizioni note di Stephen Andre
Società | Posizione | Inizio | Fine |
---|---|---|---|
TESARO INC | Ufficiale delle Risorse Umane | 01/01/2016 | 01/04/2018 |
SYNAGEVA BIOPHARMA CORP | Ufficiale delle Risorse Umane | 01/01/2012 | 01/01/2015 |
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | Ufficiale delle Risorse Umane | 01/04/2020 | - |
PANACOS PHARMACEUTICALS, INC. | Ufficiale delle Risorse Umane | - | - |
AMAG PHARMACEUTICALS, INC. | Ufficiale delle Risorse Umane | 01/03/2008 | - |
Statistiche
Distribuzione geografica
Stati Uniti | 7 |
Posizioni
Human Resources Officer | 6 |
Settori
Health Technology | 6 |
Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
PANACOS PHARMACEUTICALS, INC. | Health Technology |
CULLINAN THERAPEUTICS, INC. | Health Technology |
Aziende private | 4 |
---|---|
AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
Synageva BioPharma Corp.
Synageva BioPharma Corp. BiotechnologyHealth Technology Synageva BioPharma Corp. is a biopharmaceutical company which focuses on the discovery, development, and commercialization of therapeutic products for patients with life-threatening rare diseases and high unmet medical need. The company is currently evaluating sebelipase alfa in global clinical trials for LAL Deficiency, a lysosomal storage disease associated with liver damage and accelerated atherosclerosis in children and adults, and in infants, premature death often before six months of age. Synageva BioPharma was founded in 1993 and is headquartered in Lexington, MA. | Health Technology |
Tesaro, Inc.
Tesaro, Inc. Pharmaceuticals: MajorHealth Technology TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. The firm offers Niraparib products. The company was founded by Leon Oliver Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA. | Health Technology |
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | Finance |
- Borsa valori
- Insiders
- Stephen Andre
- Esperienza